ÂÜÀòÂÒÂ×

John Hastings joined Nonin in 2022 as CEO. Hastings has 20 years of progressive experience in the medical technology industry with a demonstrated track record of starting, building, and growing organizations. Prior to joining Nonin, he served as Executive Vice President at Cardiovascular Systems Inc, where he was responsible for research & development, quality, operations & supply chain, regulatory affairs and Strategic Ventures. He held leadership roles of increasing responsibility at Abbott Laboratories, St. Jude Medical and American Medical Systems prior to CSI.